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1. Introduction 
Antisera raised in animals against human growth 
hormone (HGH) have previously been shown to cross- 
react with human placental lactogen (HPL) [l] . 
Recently, a large homology in amino-acid sequence 
between HGH and HPL was described [2,3]. However, 
differences in the magnitude of the biological activity 
of the two hormones were observed [4]. The striking 
similarities between a pituitary and placental protein 
is intriguing and lead us to investigate whether in this 
model system for cross-reacting antisera monospecific 
antibody populations directed against HGH only can 
be isolated. 
We wish to report a resolution of antibodies in an 
anti-HGH serum into cross-reacting and monospecific 
populations by affinity chromatography using a spe- 
cific HPL-immunoadsorbent. 
2. Materials and methods 
Antiserum to HGH used throughout this study 
was obtained from a single rabbit immunized with 
HGH (NIH-GH-HSI 268A). NIH-GH-H 1207A was 
used for labelling and as standard. The experiments 
were carried out with immuno-grade HPL (HPL 196A). 
Iodination of HGH and HPL was performed by a modi- 
fication of a method reported previously [5] . We 
used Sepharose for the attachment of HPL by a modi- 
fication of methods described recently [6-81 . For 
the preparation of HPL-Sepharose, 10 ml bed volume 
North-Holland Publishing Company -~ Amsterdam 
Sepharose 6B was activated at pH 11 with 350 mg 
CNBr at room temperature for 10 min, then washed 
and incubated at pH 9 and 4” with 10 mg of a highly 
purified preparation of HPL. The course of the reac- 
tion was followed by observing the decrease in 
280 nm absorbance of the supernatant with time. 
HPL tracer was used in some experiments and the 
decrease in radioactivity of the supernatant with time 
was recorded. Within two hours more than 70 percent 
of HPL was attached to the Sepharose. A coupling of 
better than 95 percent was achieved in all experiments 
after 12 hr. VThe immunoadsorbent was thoroughly 
washed until HPL was no longer detectable in the 
washing medium and stored in 0.01 M phosphate 
buffer (pH 7.4), 0.145 M NaCl and 0.02% NaN, at 
4O. 
Anti-HGH serum was diluted 1: 10 and passed 
through a column packed with HPL-Sepharose. 
The column was washed with buffer and adsorbed 
antibodies were eluted with 3 M KSCN at neutral 
pH. The eluted fractions were dialized against buffered 
saline. The binding capacities of all fractions were de- 
termined by a modification of a radioimmunoassay 
system reported previously [9] using ’ 25 I-HGH and 
12’I-HPL as tracer. Cross reaction was checked by 
plotting a dose response curve. The data were obtained 
with a solid-phase radioimmunoassay described re- 
cently [ 131. 
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3. Results and discussion 
Antisera raised in animals against protein antigen 
usually show a mixture of serum antibodies against 
different determinants on the immunizing protein 
[lo] . Immunization with a protein which shares 
common amino acid sequences with a homologous 
protein elicits cross-reacting antibodies. Human 
growth hormone (HGH) is a protein of the anterior 
pituitary and consists of 188 amino acid residues of 
known sequence [I l] . During pregnancy a poly- 
peptide hormone termed human placental lactogen 
(HPL) is synthesized by the human placenta [ 121. 
HGH and HPL have similar molecular weights and 
amino acid composition. Eight of twenty tryptic 
peptides, including the C-terminal peptides of HGH 
and HPL are identical [3] . The similar biological and 
immunological properties of the two polypeptide 
hormones are based on the chemical similarity 
between the two. 
An antiserum to HGH was obtained from a single 
rabbit and showed a strong cross-reaction with HPL. 
Riphasic titration curves of this anti-HGH serum were 
obtained by checking its binding capacity at serial 
dilutions against lz51-HGH and *251-HPL in a radio- 
immunologic system. Furthermore, this antiserum 
showed a biphasic dose response with HPL in a radio- 
immunoassay system. This biphasic curve is charac- 
terized by an initial displacement of “’ I-HGH by 
HPL and then a prolonged plateau where increasing 
doses of HPL fail to displace the tracer. These two 
observations suggested to us the presence of two po- 
pulations of antibodies against HGH, one cross-react- 
ing and the other showing no cross-reaction with 
HPL. 
When the anti-HGH serum was passed through a 
column of HPL-Sepharose cross-reacting populations 
of antibodies were adsorbed by the HPL-Sepharose 
and almost 100 percent of the specific anti-HGH po- 
pulation were recovered in fraction 1. The results 
are reported in percent binding of tracer of specific 
activity of 100 &i/l_cg in fig. 1. The binding capacity 
of the antiserum at 1: 100 dilution before chromato- 
graphy on HPL-Sepharose was 69.0 percent against 
HGH and 64.8 percent against HPL, resp., and these 
data are shown on the ordinate in fig. 1. The concen- 
tration of fraction 1 was equivalent with a 1: 100 
dilution of the original serum. On rechromatography 
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Fig. 1. Chromatography of 1.0 ml anti-HGH serum at a 1:lO 
dilution on 1 ml bed volume of HPL-Sepharose. Elution 
was started with phosphate buffered saline (see text) con- 
taining 0.5% bovine serum albumin. 10 ml each of fractions 
1 through 7 were collected. Elution of bound antibodies 
was started at fraction 8 with 5 ml each of a 3 M KSCN so- 
lution. Percent binding of all fractions was determined by 
radioimmunoassay. Ordinnte: percentage binding of the anti- 
serum before chromatography. 
of fraction 1 on HPL-Sepharose no further adsorp- 
tion occurred and the bound antibody peak in frac- 
tion 8 was again completely adsorbed, ruling out both 
incomplete binding due to overload and non-specific 
adsorption. When anti-HGH serum was applied to 
uncoupled Sepharose no adsorption was detected 
either. This is further evidence for the specificity of 
this system. When fraction 1 was checked in a radio- 
immunoassay system no displacement of ’ *’ I-GHG 
by HPL occurred. However, a strong displacement 
and a biphasic dose response with HPL was observed 
with the original antiserum in the same system under 
otherwise identical conditions. A single dose response 
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curve was obtained for unlabelled HGH and HPL, 
resp., when the unpurified antiserum and ’ 25 I-HPL 
tracer were incubated. No standard curve could be 
obtained with fraction 1 under conditions otherwise 
identical to those of the latter experiments. 
The following experiments will only be described 
and are not shown in fig. 1. Elution of adsorbed anti- 
bodies was also attempted with KSCN at serial con- 
centrations by starting with 1 M KSCN. After five 
fractions of 5 ml each the concentration of KSCN 
in the buffer used for elution was changed to 2 M 
and another five fractions were collected. This was 
repeated for 3 and 4 M KSCN. Four distinct peaks 
were eluted suggesting several antibody populations 
with different avidities. In another experiment further 
elution was carried out with 1.5 M HCl after elution 
with 3 M KSCN was completed. A new cross-reacting 
antibody population could be eluted indicating the 
strong binding of this immunoadsorbent. 
The experiments described here have shown the 
presence of several cross-reacting populations of anti- 
bodies in this antiserum differing in their avidities. 
They have permitted the rapid isolation of a mono- 
specific anti-HGH population. Specific determinants 
in the HGH molecule must be responsible for the 
production of a monospecific antibody population, 
and the genes for the pituitary and placental hormones 
are assumed to be similar. They must contain infor- 
mation for specific amino acid sequences to account 
for monospecific antibody populations. However, the 
genes for the placental protein are activated during 
pregnancy only. 
Similar experiments were done for anti-HPL serum 
and will be reported in detail elsewhere [ 141 . We are 
currently studying that part of the HGH molecule 
which gives rise to the monospecific antibody popula- 
tion. Experiments are in progress to determine the 
relationship between specificity and avidity of anti- 
bodies. 
Acknowledgements 
We acknowledge the excellent technical assistance 
of Mrs. Neustidtl, Miss Otto and Miss Winter. HGH 
for immunization and labelling was kindly provided 
by the National Institutes of Health, Bethesda, Md., 
USA. We thank Dr. H.G. Friesen, McGill University, 
Montreal, Canada for donating the HPL preparation. 
References 
111 
[21 
[31 
[41 
151 
[61 
[71 
181 
[91 
1101 
1111 
[=I 
[I31 
1141 
S.L. Kaplan and M.M. Grumbach, J. Clin. Endocrinol. 
24 (1964) 80. 
K.J. Catt, B. Moffat and H.D. Niall, Science 157 (1967) 
321. 
L.M. Sherwood, Proc. Natl. Acad. Sci. U.S. 58 (1967) 
2307. 
M.M. Grumbach and S.L. Kaplan, in: Proc. 2nd Int. 
Congr. Endocrinology 1964, London, ed. S. Taylor 
(Excerpta Medica Foundation, 1965) p. 69 1. 
W.M. Hunter and F.C. Greenwood, Biochem. .I. 91 
(1964) 43. 
P. Cuatrecasas, M. Wilcher and C.B. Anfinsen, Proc. 
Natl. Acad. Sci. U.S. 61 (1968) 636. 
R. Ax&r, J. Porath and S. Emback, Nature 214 (1967) 
1302. 
J. Porath, R. Axdn and S. Emback, Nature 215 (1967) 
1941. 
V. Herbert, K.S. Lau, C.W. Gottlieb and S.J. Bleicher, 
J. Clin. Endocrinol. 25 (1965) 1375. 
M. Sela. B. Schechter, I. Schechter and F. Borek, Cold 
Spring Harbor Symp. Quant. Biol. 32 (1967) 537. 
C.H. Li, A.K. Liu and J.S. Dixon, J. Am. Chem. Sot. 
88 (1966) 2050. 
H.G. Friesen, S. Suwa and P. Pare, Recent Progr. Hor- 
mone Res. 25 (1969) 161. 
K.J. Catt, G.W. Tregear, H.G. Burger and C. Skermer, 
Clin. Chim. Acta 27 (1970) 267. 
J. Spona (197 1) in preparation. 
197 
